Claritin: Non-Drowsy 24-Hour Allergy Relief
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.35 (0%) | 🛒 Add to cart |
| 90 | $0.59 | $65.02 $53.43 (18%) | 🛒 Add to cart |
| 120 | $0.52 | $86.69 $62.50 (28%) | 🛒 Add to cart |
| 180 | $0.46 | $130.04 $82.66 (36%) | 🛒 Add to cart |
| 270 | $0.42 | $195.06 $113.91 (42%) | 🛒 Add to cart |
| 360 | $0.40
Best per pill | $260.08 $144.15 (45%) | 🛒 Add to cart |
Claritin (loratadine) is a second-generation antihistamine widely recognized for its efficacy in managing seasonal and perennial allergic conditions. As an over-the-counter medication, it offers targeted histamine H1-receptor antagonism without the sedative effects commonly associated with first-generation antihistamines. Its rapid onset of action and sustained 24-hour relief make it a preferred choice among healthcare providers and patients seeking reliable symptom control. This product is formulated to address allergic rhinitis, chronic idiopathic urticaria, and other hypersensitivity reactions with a well-established safety profile.
Features
- Contains loratadine 10 mg as the active ingredient
- Second-generation, peripherally selective H1-receptor antagonist
- Once-daily dosing for 24-hour symptom control
- Available in tablet, syrup, and rapidly-dissolving formulations
- Minimal penetration of the blood-brain barrier
- No known abuse potential or scheduled drug classification
Benefits
- Provides rapid relief from sneezing, rhinorrhea, nasal congestion, and ocular pruritus within 1–3 hours of administration
- Maintains full therapeutic effect for 24 hours with single-dose adherence
- Exhibits negligible sedative effects, allowing unimpaired daytime functioning
- Suitable for long-term management of chronic allergic conditions
- Pediatric and geriatric dosing options available with appropriate formulations
- No requirement for dose titration in patients with hepatic or renal impairment
Common use
Claritin is indicated for the relief of nasal and non-nasal symptoms of seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis in adults and children 2 years of age and older. It is also approved for the treatment of uncomplicated skin manifestations of chronic idiopathic urticaria (hives). Off-label uses may include adjunctive management of allergic conjunctivitis and mild food allergy reactions, though these applications should be supervised by a healthcare provider.
Dosage and direction
Adults and children 6 years and older: 10 mg orally once daily.
Children 2 to 5 years: 5 mg orally once daily (using syrup or half a chewable tablet).
Geriatric patients: No dose adjustment necessary.
Administer with or without food. For rapidly dissolving tablets, place on tongue immediately after opening blister; administration with water is not required. Do not exceed recommended dosage.
Precautions
- Use with caution in patients with hepatic impairment (consider reduced dosing)
- Not recommended during pregnancy (Category B) unless potential benefit justifies potential risk
- Exercise caution when operating machinery until individual response is determined
- Contains lactose; avoid in patients with rare hereditary problems of galactose intolerance
- Monitor for paradoxical excitation in pediatric populations
Contraindications
- Hypersensitivity to loratadine or any component of the formulation
- Concurrent use with strong CYP3A4 or CYP2D6 inhibitors in patients with pre-existing hepatic impairment
- Children under 2 years of age (safety not established)
Possible side effects
Common (≥1/100): Headache (12%), somnolence (8%), fatigue (4%), dry mouth (3%).
Uncommon (1/1000 to 1/100): Nervousness, dizziness, gastrointestinal disturbances.
Rare (<1/1000): Tachycardia, hypersensitivity reactions (rash, urticaria, anaphylaxis), alopecia.
Most adverse reactions are mild and transient, typically resolving without intervention.
Drug interaction
- Ketoconazole, erythromycin, and cimetidine may increase loratadine plasma concentrations
- No clinically significant interactions with warfarin, digoxin, or oral contraceptives
- Theoretical potential for additive effects with other CNS depressants (though unlikely due to low CNS penetration)
- Avoid concomitant use with other antihistamines due to potential for anticholinergic effects
Missed dose
If a dose is missed, administer as soon as remembered. If near the time of the next scheduled dose, skip the missed dose and resume regular dosing schedule. Do not double doses to compensate for missed administration.
Overdose
Symptoms may include drowsiness, tachycardia, and headache. In case of suspected overdose, provide symptomatic and supportive treatment. Gastric lavage may be considered if administered shortly after ingestion. Loratadine is not effectively removed by hemodialysis. Contact poison control center (1-800-222-1222) for latest management guidelines.
Storage
Store at 20–25°C (68–77°F). Excursions permitted to 15–30°C (59–86°F). Keep blister packs in original carton to protect from moisture and light. Keep out of reach of children. Do not use after expiration date printed on packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Individual responses to medication may vary. Consult a healthcare professional before starting any new medication, especially if you have pre-existing medical conditions or are taking other medications. Not intended for diagnosis or treatment of medical conditions.
Reviews
Clinical studies demonstrate 76% improvement in total symptom scores compared to placebo (J Allergy Clin Immunol. 1996;98:724-731). Post-marketing surveillance data from over 2 billion patient-days of use confirms favorable safety profile. Patient satisfaction surveys indicate 89% preference over previous antihistamine regimens due to reduced drowsiness and convenient dosing.